Kamala Harris to publish behind-the-scenes account of failed 2024 campaign
Harris, in a video posted to social media on Thursday, announced that her new book, titled "107 Days," releases in September and will provide details on what she calls "the shortest presidential campaign in modern history."
"I believe there's value in sharing what I saw, what I learned, and what I know it will take to move forward," Harris said.
Harris replaced then-President Joe Biden last July as the Democratic Party's 2024 presidential nominee after he dropped out of the race amid mounting questions over his physical and mental stamina following a disastrous debate performance a month earlier against now-President Donald Trump.
"What the world saw on the campaign trail was only part of the story," Harris teases.
The news from Harris came one day after she announced that she wouldn't run in 2026 for governor of her home state of California.
But her decision to keep her name off the ballot next year left the door open for a possible second presidential bid in 2028.
In her statement on Wednesday explaining her decision, Harris said, "For now, my leadership — and public service — will not be in elected office."
"I look forward to getting back out and listening to the American people, helping elect Democrats across the nation who will fight fearlessly, and sharing more details in the months ahead about my own plans," she said.
After losing last year's election to Trump and then serving out the remainder of her term as vice president, Harris returned to California and kept close counsel with an inner circle of confidants.
And some in her inner circle, as well as political analysts, suggested that running and winning the election in 2026 for governor of California, the nation's most populous state and home to the world's fifth-largest economy, would likely take a 2028 White House run off the table.
But with a gubernatorial run off the table, that's no longer a concern.
If Harris eventually does launch a 2028 presidential campaign, she would start her ride on the road to the White House as the most recognizable Democrat in what's expected to be a large field of contenders. And she would also come equipped with a broad fundraising network that she built up last cycle.
"She would certainly be a very serious candidate in the primary in 2028, if she runs," a Democratic strategist and veteran of multiple White House campaigns told Fox News Digital.
The strategist, who asked to remain anonymous to speak more freely, said that "a lot of Democrats think she was put in a tough spot in 2024 and deserves to have a chance to run a race on her own…she was limited in doing some of the things that politically she might have needed to do to make a cleaner break with Biden."
But Harris could also potentially be weighed down with plenty of political baggage from the 2024 campaign, when the Democrats lost not only the White House but also their Senate majority, and failed to win back control of the House.
As the party looks to escape the political wilderness, many Democrats are aiming to make a clear break with the past as they strive for a reset.
"If you're trying to take a different path for the party, it's hard to go backwards and pick the person who lost to Trump," a Democratic consultant told Fox News. "There needs to be a fresh start, a new generation."
If Harris does run, she'd have to deal with her unwavering support for Biden as his physical and mental abilities appeared to waver in front of Americans.
Republican Rep. James Comer, who as House Oversight chair is investigating the former president's use of the autopen and mental fitness while in the White House, said in an interview on Fox News' "The Ingraham Angle" that "the odds of Kamala Harris getting a subpoena are very high."
While Harris has been spending recent months mulling her decision on a gubernatorial run, other potential 2028 Democratic presidential contenders have already been making early moves as they try to move past the Biden administration and last year's election setbacks.
Among them are Govs. Gavin Newsom of California, JB Pritzker of Illinois, Josh Shapiro of Pennsylvania, Wes Moore of Maryland, Andy Beshear of Kentucky, Gretchen Whitmer of Michigan, as well as Sen. Cory Booker of New Jersey and former Biden Transportation Secretary Pete Buttigieg.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
US axes mRNA vaccine contracts, casting safety doubts
President Donald Trump's administration on Tuesday announced it would terminate 22 federal contracts for mRNA-based vaccines, questioning the safety of a technology credited with helping end the Covid pandemic and saving millions of lives. The announcement, made by Health Secretary Robert F. Kennedy Jr., marks his latest effort to weave vaccine skepticism into the core of US government policy. "We reviewed the science, listened to the experts, and acted," Kennedy said in a statement. The health department's Biomedical Advanced Research and Development Authority (BARDA) is "terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu," he added. "We're shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate." The changes affect Moderna's mRNA bird flu vaccine -- a move the company itself disclosed in May -- as well as numerous other programs, including "rejection or cancellation of multiple pre-award solicitations" from pharmaceutical giants Pfizer and Sanofi. In total, the affected projects are worth "nearly $500 million," the Department of Health and Human Services (HHS) said. Certain late-stage projects were excluded from the move "to preserve prior taxpayer investment." "Let me be absolutely clear: HHS supports safe, effective vaccines for every American who wants them," Secretary Kennedy said. "That's why we're moving beyond the limitations of mRNA and investing in better solutions." Since taking office, Kennedy, who spent two decades sowing misinformation around immunization, has overseen a major overhaul of US health policy -- firing, for example, a panel of vaccine experts that advise the government and replacing them with his own appointees. In its first meeting, the new panel promptly voted to ban a longstanding vaccine preservative targeted by the anti-vaccine movement, despite its strong safety record. He has also ordered a sweeping new study on the long-debunked link between vaccines and autism. Unlike traditional vaccines, which often use weakened or inactivated forms of the target virus or bacteria, mRNA shots deliver genetic instructions into the host's cells, prompting them to produce a harmless decoy of the pathogen and train the immune system to fight the real thing. Though in development for decades, mRNA vaccines were propelled from lab benches to widespread use through President Trump's Operation Warp Speed -- a public-private partnership led by BARDA that poured billions into companies to accelerate development. The technology's pioneers, Katalin Kariko and Drew Weissman, were awarded the 2023 Nobel Prize in Medicine for their work contributing "to the unprecedented rate of vaccine development during one of the greatest threats to human health in modern times." ia/jgc
CNBC
28 minutes ago
- CNBC
CNBC Daily Open: Trump's interview suggests he's not backing down from his policies
U.S. President Donald Trump joined CNBC's "Squawk Box" Tuesday for a lengthy interview that touched on tariffs, the Federal Reserve, the state of Russia's economy and being rejected as a customer by JPMorgan Chase and Bank of America. For those pressed on time and want a very broad TL;DR: Trump appears to be digging in on his policies. With modified country-specific "reciprocal" tariffs due to start Aug. 7 — and duties on India to be raised within the next 24 hours, according to Trump's comments during the interview — the Trump administration seems to be turning its attention to sectoral ones. Trump told CNBC that he will announce his tariff plan for semiconductors "within the next week or so." Additionally, he will impose "a small tariff" on pharmaceutical imports before ratcheting it up to 250% within a year and a half. The U.S. president doesn't look like he's backing down from his feud with the central bank, either. Days after the Fed chose to hold interest rates, Trump discussed his potential candidates to replace Jerome Powell as Fed chair. Among those contenders are former Governor Kevin Warsh and Kevin Hassett, the National Economic Council director. "Both Kevins are very good," Trump said. Whichever Kevin — or "other people that are very good, too," in Trump's words — assumes the role when Powell's term ends in May 2026 (or is truncated earlier, depending on Trump's moves), they would have to help prop up an economy that seems to be slowing, as indicated by July's startling jobs report and ISM Services index. Semiconductor tariffs in the works. In an interview with CNBC, Trump said he will announce new tariffs on semiconductors as soon as next week. He also said he'd impose a "small tariff" on pharmaceuticals before raising it to as high as 250%. Trump has four candidates for Fed chair. While the president didn't reveal their identities, he said Treasury Secretary Scott Bessent has taken himself out of consideration. Major U.S. stock indexes pull back. Stocks retreated Tuesday on ISM data that indicated the services sector nearly shrank in July. The pan-European Stoxx 600 index added 0.15%, but European semiconductor stocks fell on Trump's tariff comment. AMD's earnings fall short of expectations. That's despite the chipmaker reporting second-quarter revenue that beat Wall Street estimates. Shares of Advanced Micro Devices lost more than 6% in extended trading. [PRO] Topping expectations might not be enough. Even though the S&P 500 is on track for second-quarter earnings growth of almost double digits, compared with a year earlier, investors are giving a muted response, according to Goldman Sachs. Russia's economy 'stinks,' Trump says, and lower oil prices will stop its warmachine The rift between Moscow and Washington looks set to deepen. "Putin will stop killing people if you get energy down another $10 a barrel. He's going to have no choice because his economy stinks," Trump, told CNBC's "Squawk Box" on Tuesday. The comments come after relations between Moscow and Washington, which remained cordial at the start of Trump's second term in office despite the ongoing war, soured in recent weeks.
Bloomberg
28 minutes ago
- Bloomberg
Trump Ramps Up Tariff Blitz With India, Pharma, Chips in Sights
President Donald Trump said he'd impose increased tariffs on countries buying energy from Russia while clarifying that levies on semiconductor and pharmaceutical imports would be announced 'within the next week or so.' In a divergent approach toward Asia's giants, Trump said he'd raise tariffs on India 'very substantially over the next 24 hours,' accusing its Russian oil purchases of 'fueling the war machine.' By contrast, he said he was 'very close to a deal' with China to extend a trade truce that saw the two countries agree to reduce tit-for-tat tariff hikes and ease export restrictions on rare earth magnets and certain technologies.
